NDC 0363-6248 Walgreens Nighttime Kids Honey Cold Cough Congestion
Doxylamine Succinate, Phenylephrine Hydrochloride And Dextromethorphan Hydrobromide Liqui...
Product Information
What is NDC 0363-6248?
The NDC code 0363-6248 is assigned by the FDA to the product Walgreens Nighttime Kids Honey Cold Cough Congestion which is a human over the counter drug product labeled by Walgreens Co. The generic name of Walgreens Nighttime Kids Honey Cold Cough Congestion is doxylamine succinate, phenylephrine hydrochloride and dextromethorphan hydrobromide. The product's dosage form is liquid and is administered via oral form. The product is distributed in a single package with assigned NDC code 0363-6248-08 236 ml in 1 bottle, plastic . This page includes all the important details about this product, including active and inactive ingredients, pharmagologic classes, product uses and characteristics, UNII information, RxNorm crosswalk and the complete product label.
Product Details
What are Walgreens Nighttime Kids Honey Cold Cough Congestion Active Ingredients?
- DEXTROMETHORPHAN HYDROBROMIDE 10 mg/15mL - Methyl analog of DEXTRORPHAN that shows high affinity binding to several regions of the brain, including the medullary cough center. This compound is an NMDA receptor antagonist (RECEPTORS, N-METHYL-D-ASPARTATE) and acts as a non-competitive channel blocker. It is one of the widely used ANTITUSSIVES, and is also used to study the involvement of glutamate receptors in neurotoxicity.
- DOXYLAMINE SUCCINATE 6.25 mg/15mL
- PHENYLEPHRINE HYDROCHLORIDE 5 mg/15mL - An alpha-1 adrenergic agonist used as a mydriatic, nasal decongestant, and cardiotonic agent.
Pharmacologic Class(es)
- Adrenergic alpha1-Agonists - [MoA] (Mechanism of Action)
- Antihistamine - [EPC] (Established Pharmacologic Class)
- Histamine Receptor Antagonists - [MoA] (Mechanism of Action)
- Sigma-1 Agonist - [EPC] (Established Pharmacologic Class)
- Sigma-1 Receptor Agonists - [MoA] (Mechanism of Action)
- Uncompetitive N-methyl-D-aspartate Receptor Antagonist - [EPC] (Established Pharmacologic Class)
- Uncompetitive NMDA Receptor Antagonists - [MoA] (Mechanism of Action)
- alpha-1 Adrenergic Agonist - [EPC] (Established Pharmacologic Class)
* Please review the disclaimer below.